Article Text

Download PDFPDF
Correspondence to viewpoint ‘Defining refractory rheumatoid arthritis’ by Buch
  1. Nadia MT Roodenrijs,
  2. Maria JH de Hair,
  3. Marlies C van der Goes,
  4. Johannes WG Jacobs
  1. Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  1. Correspondence to Nadia MT Roodenrijs, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht 3508GA, The Netherlands; N.M.T.Roodenrijs{at}umcutrecht.nl

Statistics from Altmetric.com

With great interest, we read the clinically highly relevant viewpoint on ‘Defining refractory rheumatoid arthritis’ by Professor Maya H. Buch.1 The author classifies refractory rheumatoid arthritis (RA) into ‘intrinsic refractory’ (persistent inflammation, no antidrug antibodies (ADA)), ‘pharmacokinetic refractory’ (persistent inflammation, presence of ADA) or ‘false positive refractory’ (no persistent inflammation, no ADA). Professor Buch highlights the gap of knowledge in the understanding of refractory RA and states that consistent definitions and criteria are required for future research. We fully agree with the author that this subpopulation of patients with RA is facing unmet needs, …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles